Agnieszka E. Synowiec

Szaserow 128 Street
Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Pharmacological Modulators of TCTP: Opportunities and Challenges for Drug Repurposing.

Pharmacological Modulators of TCTP: Opportunities and Challenges for Drug Repurposing.

Journal: International journal of molecular sciences

Published: April 23, 2026

Extracellular Vesicles in Endometriosis: A Comprehensive Review of Biological Insights and Methodological Challenges.

Extracellular Vesicles in Endometriosis: A Comprehensive Review of Biological Insights and Methodological Challenges.

Journal: International journal of molecular sciences

Published: April 20, 2026

Hypoxia alters the response of ovarian cancer cells to the mitomycin C drug.

Hypoxia alters the response of ovarian cancer cells to the mitomycin C drug.

Journal: Frontiers in cell and developmental biology

Published: February 11, 2025

The role of selected NKG2DLs such as MICA, MICB and ULBP4 as potential markers in multiple sclerosis.

The role of selected NKG2DLs such as MICA, MICB and ULBP4 as potential markers in multiple sclerosis.

Journal: Scientific reports

Published: January 12, 2025

The current state of knowledge on the role of NKG2D ligands in multiple sclerosis and other autoimmune diseases.

The current state of knowledge on the role of NKG2D ligands in multiple sclerosis and other autoimmune diseases.

Journal: Frontiers in molecular neuroscience

Published: September 08, 2024

Assessment of urine calprotectin and YKL-40 levels in urinary tract infection diagnosis in children under 2 years of age.

Assessment of urine calprotectin and YKL-40 levels in urinary tract infection diagnosis in children under 2 years of age.

Journal: Scientific reports

Published: July 30, 2024

Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy.

Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy.

Journal: International journal of molecular sciences

Published: January 16, 2023

Polyploidy formation in cancer cells: How a Trojan horse is born.

Polyploidy formation in cancer cells: How a Trojan horse is born.

Journal: Seminars in cancer biology

Published: October 28, 2020

Transcriptome Remodeling in Gradual Development of Inverse Resistance between Paclitaxel and Cisplatin in Ovarian Cancer Cells.

Transcriptome Remodeling in Gradual Development of Inverse Resistance between Paclitaxel and Cisplatin in Ovarian Cancer Cells.

Journal: International journal of molecular sciences

Published: October 02, 2020

Role of WNT/β-Catenin Pathway as Potential Prognostic and Predictive Factors in Renal Cell Cancer Patients Treated With Everolimus in the Second and Subsequent Lines.

Role of WNT/β-Catenin Pathway as Potential Prognostic and Predictive Factors in Renal Cell Cancer Patients Treated With Everolimus in the Second and Subsequent Lines.

Journal: Clinical genitourinary cancer

Published: October 16, 2017

Erythropoietin and drug resistance in breast and ovarian cancers

Erythropoietin and drug resistance in breast and ovarian cancers

Journal: Ginekologia polska

Published: May 23, 2016

Cystatin C as a predictor factor in patients with renal cell carcinoma treated by everolimus.

Cystatin C as a predictor factor in patients with renal cell carcinoma treated by everolimus.

Journal: Cancer chemotherapy and pharmacology

Published: April 09, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026